MTR Antikörper (C-Term)
Kurzübersicht für MTR Antikörper (C-Term) (ABIN633804)
Target
Alle MTR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- MTR antibody was raised against the C terminal of MTR
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Affinity purified
-
Immunogen
- MTR antibody was raised using the C terminal of MTR corresponding to a region with amino acids GSEQLDVADLRRLRYKGIRPAPGYPSQPDHTEKLTMWRLADIEQSTGIRL
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
MTR Blocking Peptide, (ABIN938943), is also available for use as a blocking control in assays to test for specificity of this MTR antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MTR antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MTR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR))
-
Andere Bezeichnung
- MTR
-
Hintergrund
- MTR is the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G.
-
Molekulargewicht
- 140 kDa (MW of target protein)
-
Pathways
- Methionine Biosynthetic Process
Target
-